Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man

被引:24
作者
Newby, DE
Masumori, S
Johnston, NR
Boon, NA
Webb, DJ
机构
[1] Univ Edinburgh, Western Gen Hosp, Clin Pharmacol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Edinburgh, Western Gen Hosp, Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Yokohama City Univ, Sch Med, Dept Internal Med, Kanazawa Ku, Yokohama, Kanagawa 236, Japan
关键词
angiotensin II; losartan; sodium depletion; arteries; blood flow; human;
D O I
10.1016/S0008-6363(97)00171-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Both endothelin-1 and nitric oxide make important contributions to the maintenance of basal peripheral arteriolar tone. However, the role of angiotensin II, a key hormone regulating cardiovascular and renal function, in the regulation of peripheral vascular tone has not been fully characterised. Methods: Using local intra-arterial administration of losartan, a selective angiotensin II type 1 (AT(1)) receptor antagonist, we examined the contribution of endogenous angiotensin II to the maintenance of basal and sympathetically stimulated vascular tone in the forearm of healthy man under conditions of sodium repletion and depletion. The effects of losartan on responses to exogenous angiotensin I, angiotensin II, bradykinin and noradrenaline were also determined. Results: Losartan, in keeping with its actions as a selective AT(1) receptor antagonist, inhibited responses to angiotensin I and II, but had no effect on responses to bradykinin or noradrenaline. The dose of angiotensin II required to cause a 20% vasoconstriction was 40- and 250-fold greater with 30 and 300 mu g/min of losartan, respectively. However, in sodium replete subjects, losartan alone caused no significant changes in basal forearm blood flow (95% confidence interval of -7.2 to +8.0%), forearm vascular resistance or sympathetically stimulated forearm vasoconstriction. Sodium depletion elevated plasma renin activity and angiotensin II concentrations (p less than or equal to 0.002) after which acute local administration of losartan increased forearm blood flow in a dose dependent manner (maximum of 69 +/- 17%; p < 0.001). Conclusions: Endogenous angiotensin II does not contribute to the acute local maintenance of basal peripheral vascular tone in healthy man except under conditions of renin-angiotensin system activation such as sodium depletion. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:268 / 275
页数:8
相关论文
共 36 条
[1]   NEUROPEPTIDE-Y ANGIOTENSIN-II INTERACTIONS IN CENTRAL CARDIOVASCULAR REGULATION OF THE RAT [J].
AGUIRRE, JA ;
FUXE, K ;
HEDLUND, P ;
NARVAEZ, JA ;
CINTRA, A ;
ROSEN, L ;
AGNATI, LF .
BRAIN RESEARCH, 1991, 566 (1-2) :61-69
[2]  
Baan J, 1996, CARDIOVASC RES, V32, P973
[3]   LOCAL INHIBITION OF CONVERTING ENZYME AND VASCULAR-RESPONSES TO ANGIOTENSIN AND BRADYKININ IN THE HUMAN FOREARM [J].
BENJAMIN, N ;
COCKCROFT, JR ;
COLLIER, JG ;
DOLLERY, CT ;
RITTER, JM ;
WEBB, DJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1989, 412 :543-555
[4]   MEASURING FOREARM BLOOD-FLOW AND INTERPRETING THE RESPONSES TO DRUGS AND MEDIATORS [J].
BENJAMIN, N ;
CALVER, A ;
COLLIER, J ;
ROBINSON, B ;
VALLANCE, P ;
WEBB, D .
HYPERTENSION, 1995, 25 (05) :918-923
[5]   QUANTITATIVE-ANALYSIS OF ACUTE RESPONSE TO HEMORRHAGE OF RENIN-ANGIOTENSIN-VASOCONSTRICTOR FEEDBACK LOOP IN AREFLEXIC DOGS [J].
BROUGH, RB ;
COWLEY, AW ;
GUYTON, AC .
CARDIOVASCULAR RESEARCH, 1975, 9 (06) :722-733
[6]   ENDOTHELIN IS A POTENT LONG-LASTING VASOCONSTRICTOR IN MEN [J].
CLARKE, JG ;
BENJAMIN, N ;
LARKIN, SW ;
WEBB, DJ ;
DAVIES, GJ ;
MASERI, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (06) :H2033-H2035
[7]   PREJUNCTIONAL ANGIOTENSIN-II RECEPTORS - FACILITATION OF NOREPINEPHRINE RELEASE IN THE HUMAN FOREARM [J].
CLEMSON, B ;
GAUL, L ;
GUBIN, SS ;
CAMPSEY, DM ;
MCCONVILLE, J ;
NUSSBERGER, J ;
ZELIS, R .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :684-691
[8]   COMPARISON OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH ANGIOTENSIN-II RECEPTOR ANTAGONISM IN THE HUMAN FOREARM [J].
COCKCROFT, JR ;
SCIBERRAS, DG ;
GOLDBERG, MR ;
RITTER, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (04) :579-584
[9]  
COLLIER JG, 1973, LANCET, V1, P72
[10]   LOSARTAN IN HEART-FAILURE - HEMODYNAMIC-EFFECTS AND TOLERABILITY [J].
CROZIER, I ;
IKRAM, H ;
AWAN, N ;
CLELAND, J ;
STEPHEN, N ;
DICKSTEIN, K ;
FREY, M ;
YOUNG, J ;
KLINGER, G ;
MAKRIS, L ;
RUCINSKA, E .
CIRCULATION, 1995, 91 (03) :691-697